Accueil > Liste des personnes > CV de Patricia Marino

Patricia Marino

Economiste

INSERM UMR912 (SE4S)

Tél. : +33 (0) 491223502
Fax : +33 (0) 491223504

Adresse : UMR912
Equipe CanBioS,
Institut Paoli-Calmettes,
232 Bd Sainte Marguerite
13273 Marseille cedex 09
France

L'évaluation économique des innovations dans le domaine de la pharmacogénomique.
Prise en compte de la qualité de vie des patients dans l'analyse économique.

Marino P, Siani C, Roché H et al. Cost-effectiveness of adjuvant docetaxel for node-positive breast cancer patients: results of the PACS 01 economic study. Annals of Oncolgy, 2010 (in press).
Marino P. Measuring the cost of chemotherapy is important, but it is not enough. Annals of Oncology, 2008, 19(3):409-10.
Marino P, Roché H, Biron P et al. Deterioration of Quality of Life of High-Risk Breast Cancer Patients Treated with High-Dose Chemotherapy: The PEGASE 01 Quality of Life Study. Value in Health, 2008, 11(4):709-18.
Marino P., Roche H. and Moatti JP. High-dose chemotherapy for high-risk breast cancer patients: a clinical and economic assessment using a quality-adjusted survival analysis. American Journal of Clinical Oncology, 2008, 31(2):117-24.
Marino P, Siani C, Roché H, Moatti JP; PEGASE Group. Impact of uncertainty on cost-effectiveness analysis of medical strategies: the case of high-dose chemotherapy for breast cancer patients. International Journal of Technology Assessment in Health Care;2005, 21(3):342-50.
Marino P, Le Corroller AG, Palangié T et al. Can sequential administration minimise the cost of high dose chemotherapy? An economic assessment in inflammatory breast cancer. Pharmacoeconomics. 2003, 21(11):807-18